GLP3-RT/GLP2-TZ 20mg / 40mg

Product Details

Retatrutide/Tirzepatide is a two-component research blend containing synthetic peptides with overlapping receptor activity. GLP3-RT activates GIP, GLP-1, and glucagon receptors, while GLP2-TZ activates GIP and GLP-1 receptors.

The individual components have been studied in metabolic research involving receptor signaling, glucose homeostasis, energy balance, and lipid metabolism. This specific combined formulation is not a standardized or clinically established drug product.

Molecular Profile

Structure: Two-component synthetic peptide blend

Components: GLP3-RT and GLP2-TZ

Retatrutide Structure: 39-amino-acid lipidated synthetic peptide

Tirzepatide Structure: 39-amino-acid modified peptide conjugated to a C20 fatty diacid moiety

Molecular Formula: Not applicable as a single formula; each component has a distinct molecular structure

Receptor Activity: GIP, GLP-1, and glucagon receptor agonism

Research Focus: Metabolic receptor signaling, glucose homeostasis, energy balance, and lipid metabolism

Research Use Only: Not intended for human or veterinary use.